3 results
06/Jun/2023
06/Jun/2023
DOI: 10.31744/einstein_journal/2023RW0351
ABSTRACT Introduction COVID-19 is associated with endothelial activation and systemic inflammation; consequently, statins can be used in its treatment as they have anti-inflammatory, antithrombotic, and profibrinolytic properties and may interfere with COVID-19 viral entry into cells through disruption of cell membrane lipid rafts. Objective We performed a meta-analysis of randomized clinical trials that compared statin therapy to placebo or to standard care in adult patients hospitalized for COVID-19. Methods We searched the MEDLINE, EMBASE, and Cochrane Library databases for all-cause […]
Keywords: Atorvastatin; Coronavirus infections; COVID-19; Hydroxymethylglutaryl-CoA reductase inhibitors; SARS-CoV-2
22/Mar/2022
22/Mar/2022
DOI: 10.31744/einstein_journal/2022RW6339
ABSTRACT Objective To evaluate whether the addition of statins to the new antiandrogens (enzalutamide or abiraterone) affects overall survival in patients with metastatic castration-resistant prostate cancer. Methods We searched studies in English language including the keywords statins, overall survival, and metastatic castration-resistant prostate cancer, at PubMed® (MEDLINE®), Embase and Cochrane databases. Results A total of 195 articles were initially identified, but only four met the inclusion criteria and were selected for the meta-analysis. A total of 955 patients, 632 on […]
Keywords: Androgen antagonists; Hydroxymethylglutaryl-CoA reductase inhibitors; Prostatic neoplasms, castration-resistant; Survival rate
22/May/2019
DOI: 10.31744/einstein_journal/2019AO4399
ABSTRACT Objective: To determine whether pre-hospital statin use is associated with lower renal replacement therapy requirement and/or death during intensive care unit stay. Methods: Prospective cohort analysis. We analyzed 670 patients consecutively admitted to the intensive care unit of an academic tertiary-care hospital. Patients with ages ranging from 18 to 80 years admitted to the intensive care unit within the last 48 hours were included in the study. Results: Mean age was 66±16.1 years old, mean body mass index 26.6±4/9kg/m2 […]
Keywords: C-reactive protein; Hydroxymethylglutaryl-CoA reductase inhibitors; Intensive care units; Mortality; Renal replacement therapy